FDA accepts Connetics Corp. NDA filing for Extina


Source: www.PRNewswire.com Connetics Corp., a specialty pharmaceutical company focused on dermatology announced Thursday, April 8 that it has received confirmation that the FDA has accepted for filing the company's NDA for Extina, as of Jan. 26, 2004, with a user fee goal date of Sept. 24, 2004.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.